Ignite Creation Date:
2024-05-05 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 9:56 AM
Study NCT ID:
NCT00771953
Status:
COMPLETED
Last Update Posted:
2019-10-30
First Post:
2008-10-10
Brief Title:
0822GCC Phase 2 Study of Efficacy and Safety of ApricoxibPlacebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Organization Data
Organization:
University of Maryland Baltimore
Class:
OTHER
Study ID:
HP-00043076 0822GCC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Maryland Baltimore
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Tragara Pharmaceuticals Inc | INDUSTRY |